FDA.reportPublic FDA data

eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral Suspension

RxCUI
1859498
RxNorm name
eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral Suspension
Display name
eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral Suspension
Full name
eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PROMACTAELTROMBOPAG OLAMINENovartis Pharmaceuticals Corporation7714a0ed-34bb-46e6-a0a5-b363908b22c22025-12-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1859498
EltrombopagELTROMBOPAG OLAMINECamber Pharmaceuticals, Inc.8f6499f0-4774-4f1e-8ab5-145c1fe644012025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1859498

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7714a0ed-34bb-46e6-a0a5-b363908b22c2eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral SuspensionSY31These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 200820251218
7714a0ed-34bb-46e6-a0a5-b363908b22c2eltrombopag 25 MG Powder for Oral SuspensionSCD31These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 200820251218
7714a0ed-34bb-46e6-a0a5-b363908b22c2eltrombopag 25 MG Powder for Oral SuspensionPSN31These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 200820251218
8f6499f0-4774-4f1e-8ab5-145c1fe64401eltrombopag 25 MG Powder for Oral SuspensionPSN1These highlights do not include all the information needed to use ELTROMBOPAG FOR ORAL SUSPENSION safely and effectively. See full prescribing information for ELTROMBOPAG FOR ORAL SUSPENSION. ELTROMBOPAG for oral suspension Initial U.S. Approval: 200820250327
8f6499f0-4774-4f1e-8ab5-145c1fe64401eltrombopag (as eltrombopag olamine) 25 MG Powder for Oral SuspensionSY1These highlights do not include all the information needed to use ELTROMBOPAG FOR ORAL SUSPENSION safely and effectively. See full prescribing information for ELTROMBOPAG FOR ORAL SUSPENSION. ELTROMBOPAG for oral suspension Initial U.S. Approval: 200820250327
8f6499f0-4774-4f1e-8ab5-145c1fe64401eltrombopag 25 MG Powder for Oral SuspensionSCD1These highlights do not include all the information needed to use ELTROMBOPAG FOR ORAL SUSPENSION safely and effectively. See full prescribing information for ELTROMBOPAG FOR ORAL SUSPENSION. ELTROMBOPAG for oral suspension Initial U.S. Approval: 200820250327